Cardiac Magnetic Resonance in Children With Muscular Dystrophy

Sponsor
Cooperative International Neuromuscular Research Group (Other)
Overall Status
Completed
CT.gov ID
NCT01081080
Collaborator
National Institutes of Health (NIH) (NIH)
20
2
18
10
0.6

Study Details

Study Description

Brief Summary

This protocol will exploit novel state of the art cardiovascular magnetic resonance techniques to examine important changes in the heart in children with muscular dystrophy. The purpose of this study is to compare cardiac magnetic resonance (CMR) with the collected cardiac outcome data obtained in protocol: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
PITT0110 - Cardiac Magnetic Resonance: A Parallel Protocol to Cardiac Outcome Measures in Children With Muscular Dystrophy
Study Start Date :
Apr 1, 2010
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Oct 1, 2011

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Participant enrolled in the CINRG study: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy
    Exclusion Criteria:
    • Pregnant woman (when uncertain, participants will undergo urine testing) or lactating women

    • Decompensated congestive heart failure (unable to lie flat during CMR)

    • Impaired renal excretory function (calculated Glomerular Filtration Rate less than 30mL/min)

    • Contra-indications to Magnetic Resonance Imaging:

    • Cardiac pacemaker or implantable defibrillator

    • Cerebral aneurysm clip

    • Neural stimulator

    • Metallic ocular foreign body

    • Harrington-rod

    • Any implanted device (i.e. insulin pump, drug infusion device)

    • Claustrophobia

    • Metal shrapnel or bullet

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's National Medical Center Washington District of Columbia United States 20010
    2 University of Pittsburgh Pittsburgh Pennsylvania United States 15213

    Sponsors and Collaborators

    • Cooperative International Neuromuscular Research Group
    • National Institutes of Health (NIH)

    Investigators

    • Study Chair: Paula R Clemens, MD, University of Pittsburgh

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01081080
    Other Study ID Numbers:
    • PITT0110
    First Posted:
    Mar 5, 2010
    Last Update Posted:
    Jan 11, 2013
    Last Verified:
    Jan 1, 2013

    Study Results

    No Results Posted as of Jan 11, 2013